Neurometrix Inc
(NURO)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,880 | -3,111 | -1,574 | -4,417 | -3,725 |
| Depreciation Amortization | -46 | -53 | -99 | -27 | -94 |
| Accounts receivable | 32 | -100 | 71 | -336 | -392 |
| Accounts payable and accrued liabilities | -143 | -187 | 32 | 84 | 255 |
| Other Working Capital | -124 | 230 | 323 | -1,713 | -329 |
| Other Operating Activity | 526 | 648 | 126 | 1,119 | 478 |
| Operating Cash Flow | $-4,634 | $-2,573 | $-1,121 | $-5,289 | $-3,806 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,197 | -600 | -837 | -16,789 | N/A |
| PPE Investments | -138 | N/A | N/A | -23 | -23 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -18,921 |
| Investing Cash Flow | $1,058 | $-600 | $-837 | $-16,812 | $-18,945 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 702 | 700 | 0 | 3,864 | 1,951 |
| Financing Cash Flow | $702 | $700 | $0 | $3,864 | $1,951 |
| Beginning Cash Position | 4,335 | 4,335 | 4,335 | 22,572 | 22,572 |
| End Cash Position | 1,461 | 1,863 | 2,377 | 4,335 | 1,772 |
| Net Cash Flow | $-2,875 | $-2,472 | $-1,958 | $-18,237 | $-20,800 |
| Free Cash Flow | |||||
| Operating Cash Flow | -4,634 | -2,573 | -1,121 | -5,289 | -3,806 |
| Capital Expenditure | -138 | N/A | N/A | -23 | -23 |
| Free Cash Flow | -4,773 | -2,573 | -1,121 | -5,313 | -3,830 |